3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasm Metastasis
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Interventions
talazoparib
1
olaparib
1
Pluvicto
1
Lutetium-177
1
Lutetium
1
CX 5461
1
BAY 2315497
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metastatic Castration Resistant Prostate Cancer (mCRPC)
×
CX 5461
×
Clear all
NCT05425862
2023-12-11
REPAIR
Peter MacCallum Cancer Centre, Australia
Phase 1
Suspended
48 enrolled